文献速递母胎医学产科

嵌合比例对cfDNA筛查阳性预测值的影响

Impact of mosaicism ratio on positive predictive value of cfDNA screening.
PubMed 文献 · Prenat Diagn · 2020-11-25

该研究在单一临床实验室分析了22个月内13、18、21三体阳性的cfDNA标本,计算嵌合比例(MR)并据此分层比较阳性预测值(PPV)。结果显示三种三体在「嵌合」与「非嵌合」范围及「低嵌合」与「高嵌合」之间的PPV均有显著差异,提示MR可能部分影响PPV,可用于更个性化的风险评估。

要点

  • 13三体最常以嵌合形式出现,其次为18三体和21三体。
  • 三种三体的PPV在嵌合与非嵌合范围间均有显著差异。
  • 低嵌合与高嵌合分类间的PPV也存在显著差异。

核心结论

  • cfDNA筛查结果的PPV可能部分受该结果对应的嵌合比例影响。
  • 基于MR分层的数据或有助于对cfDNA阳性患者进行更个性化的风险评估。

研究设计与样本

  • 回顾性分析单一临床实验室22个月内13、18、21三体阳性且有诊断结局的cfDNA标本。
  • 对每个阳性标本计算嵌合比例(MR),即受非整倍体影响的cfDNA比例除以标本总体胎儿分数。
  • 按不同MR范围计算并分析PPV。

主要发现

  • 13三体是最常见以嵌合形式出现的非整倍体,其次为18三体和21三体。
  • 三种三体在MR处于「嵌合」与「非嵌合」范围的样本间PPV均有显著差异。
  • 三种三体在「低嵌合」与「高嵌合」分类结果间PPV也有显著差异。

临床怎么用

  • 对cfDNA阳性结果可结合MR分层解读,辅助个体化风险评估。
  • MR处于嵌合范围时需注意PPV可能不同,应结合诊断性检查确认。

局限性

  • 研究仅基于单一临床实验室22个月的数据,外推需谨慎。
  • 原文未报告具体样本量、PPV数值及置信区间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the relationship between the fraction of cell-free DNA (cfDNA) affected by aneuploidy compared to the overall fetal fraction of a prenatal screening specimen and its effect on positive predictive value (PPV). METHOD: CfDNA specimens positive for trisomy 13, 18, and 21 with diagnostic outcomes were analysed over a 22-month period in one clinical laboratory. For each positive specimen, a "mosaicism ratio" (MR) was calculated by dividing the fraction of cfDNA affected by aneuploidy by the overall fetal fraction of the specimen. PPVs were calculated and analyzed based on various MR ranges. RESULTS: Trisomy 13 was the aneuploidy most commonly seen in mosaic form, followed by trisomy 18 and trisomy 21. Significant differences in positive predictive values were noted for all three trisomies between samples with an MR in the "mosaic" versus "non-mosaic" range, as well as between results classified as "low-mosaic" versus "high-mosaic." CONCLUSION: PPVs may be influenced, in part, by the mosaicism ratio associated with a particular result. The data generated from this study may be useful in providing more personalized risk assessments for patients with positive cfDNA screening results.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Rafalko JM, Caldwell S, Tynan J, et al. Impact of mosaicism ratio on positive predictive value of cfDNA screening. Prenat Diagn. 2020. PMID: 33151555. doi:10.1002/pd.5863

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。